Last updated: March 15, 2026
What is the scope of patent IL233419?
Israel patent IL233419 pertains to a pharmaceutical invention. It claims a specific formulation, composition, or method related to a drug, typically targeting a disease or condition. The patent's breadth depends on the structural features, therapeutic applications, and manufacturing processes outlined in its claims.
Key features:
- The patent covers a novel compound, combination, or formulation.
- The scope includes methods of producing or using the claimed compound.
- The claims aim to prevent third-party creation of similar formulations or uses within the protected territory.
The patent's description likely details the chemical structure, potential indications, and manufacturing methods, providing broad or narrow protection based on specific claims.
How are the patent claims structured?
Patent IL233419 comprises a set of claims divided into independent and dependent categories:
Independent Claims
- Define the core invention, such as a novel chemical entity or therapeutic method.
- Provide broad protection; for example, the molecule's structural formula or its use for specific indications.
- Typically, there is at least one independent claim.
Dependent Claims
- Add specific limitations on the independent claims.
- Cover variations such as salt forms, dosage forms, methods of synthesis, or specific use cases.
- Narrow the scope but clarify the boundaries of the invention.
Sample claim structure:
| Claim Type |
Focus |
Scope |
| Independent |
A pharmaceutical compound or method |
Broad, usually encompassing all variants within the core invention |
| Dependent |
Salt form, delivery mechanism, or specific use |
Narrower, providing fallback protection for variations |
What is the patent landscape surrounding IL233419?
Prior Art Landscape
- The landscape comprises patents on similar compounds, formulations, or indications.
- The key is to evaluate whether IL233419 introduces an inventive step over existing patents.
- Related patents may include filings in major jurisdictions like US, EP, CN, or WO for similar molecules or indications.
Patent families
- IL233419 likely belongs to a patent family with counterparts filed in other jurisdictions.
- Analysis of these counterparts reveals the geographical scope and potential licensing or litigation risks.
Competitive filings
- Identifies major competitors filing similar or overlapping patents.
- Patent mappings show instances of infringement or freedom-to-operate assessments.
Legal status
- Active, pending, or expired.
- Strategic importance varies accordingly.
Patent classification
- Likely classified under the International Patent Classification (IPC) codes related to pharmaceuticals, chemistry, or specific therapeutic areas (e.g., A61K).
Patent expiry timeline
- Typically 20 years from filing date, subject to maintenance fees.
- For IL233419, the filing date and subsequent maintenance status influence its expiration.
Recent legal developments and landscape shifts
- Patent disputes may arise if similar patents exist.
- Judgments in key jurisdictions could impact enforceability.
- Patent office policies favoring patentability in certain areas or standards of novelty and inventive step influence the patent's strength.
Evaluation of patent protection strength
- Breadth of claims influences market exclusivity.
- Overlap with prior art threatens validity.
- Narrow claims are easier to design around but offer less protection.
Summary of implications
- For potential licensees or competitors, understanding claim scope is critical.
- For patent holders, maintaining the patent's validity and defending against challenges is essential.
Legal and strategic considerations:
- Monitor for similar filings in new jurisdictions.
- Evaluate potential infringement risks.
- Consider opportunities for patent term extension or supplementary protection certificates, if applicable.
Key Takeaways
- IL233419 covers a specific pharmaceutical compound or method with defined claims offering varying breadths.
- The patent landscape includes related filings in key territories with overlaps or gaps influencing freedom to operate.
- Stakeholders must analyze claim language for potential vulnerability or strength.
- The patent's geopolitical coverage, legal status, and collaboration opportunities depend on its family members and national phase entries.
- Ongoing legal developments and patent office policies will shape its enforceability.
FAQs
1. How broad are the claims of IL233419?
The claims likely encompass the core compound or therapeutic method with some scope for variations. Exact breadth depends on claim language, but typically, independent claims define the broadest protection.
2. Does IL233419 face any known similar patents?
It may overlap with patents filed in major jurisdictions related to the same or similar chemical entities. Patent landscape reports can clarify potential conflicts.
3. What is the potential for patent challenge or infringement?
Strength depends on novelty, inventive step, and claim scope. Prior art searches and validity assessments are necessary for definitive conclusions.
4. Will IL233419 provide patent life beyond 2030?
If filed recently, expiration is around 2040, minus any term adjustments or extensions. Maintenance fees influence the active status.
5. How does the patent landscape impact commercial strategy?
Understanding overlapping patents informs licensing negotiations, research directions, and risk management strategies.
References
[1] Israeli Patent Office. (2023). Patent search and legal status information.
[2] WIPO. (2023). International Patent Classification (IPC).
[3] EPO. (2023). Patent landscape reports for pharmaceutical inventions.
[4] USPTO. (2023). Patent examination guidelines and legal considerations.
[5] World Intellectual Property Organization. (2023). Patent term adjustments and extensions.
